SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently seeing intense community debate as investors weigh the stock's defensive reputation against its recent price volatility and ongoing regulatory uncertainty. While some traders are focused on short-term technical setups and potential catalysts from upcoming CMS Medicare Advantage rate decisions, many are questioning if the stock is a value-buy opportunity or a long-term trap.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing significant investor attention driven by its strategic pivot into domestic pharmaceutical manufacturing and advanced materials, with the community actively speculating on the potential for government contracts and a major corporate revaluation. Market participants are closely monitoring the company's strengthened balance sheet and potential takeover prospects, while ongoing discussions frequently highlight the stock's role as a play on U.S. supply chain independence.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure as investors grapple with legal uncertainty following court rulings regarding the addictive nature of its social media platforms. The community is sharply divided, with some investors viewing the decline as a major buying opportunity due to strong underlying cash flow and AI integration, while others fear long-term liability risks and regulatory headwinds that could fundamentally disrupt the company's business model.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is trending as the company issued a vigorous, data-backed rebuttal against a short-seller report, providing evidence to refute allegations of channel stuffing and business malpractice. Investors are actively debating the long-term outlook, with many expressing strong confidence in management's growth strategy and share buybacks while closely monitoring institutional support and the stock's volume.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending as investors weigh strong earnings performance and consistent guidance raises against the broader volatility in the software sector. The community is actively debating the company's competitive position against legacy players like The Trade Desk, with many bulls pointing to recent AI product launches and institutional accumulation as primary catalysts for a potential rebound.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Investors are actively weighing the impact of escalating Middle East tensions and shifting energy policies against historically high market valuations. Amid these macroeconomic uncertainties, community sentiment remains sharply polarized between those rotating into defensive positions or cash and those aggressively adding to their long-term positions in major ETFs like VOO to capitalize on current volatility.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The SPY is experiencing heightened volatility as market participants navigate intensifying geopolitical tensions, particularly surrounding the ongoing conflict in Iran. The community is deeply divided, with many debating the impact of potential ground troop deployments, the reliability of official diplomatic updates, and whether to hold positions through the weekend amid the uncertainty.

Blacksky Technology, Inc. is a space-based intelligence company, which engages in the business of delivering real-time imagery, analytics, and high-frequency monitoring of most critical and strategic locations, economic assets, and events. The firm is also involved in providing geospatial intelligence, imagery and related data analytic products and services, and mission systems that include the development, integration, and operation of satellite and ground systems to government and commercial customers. The company was founded in 2014 and is headquartered in Herndon, VA.

BlackSky Technology Inc - Ordinary Shares - Class A

BlackSky Technology is experiencing significant volatility and a notable price correction as investors weigh the company's long-term potential in the satellite intelligence sector against frustration over launch delays and a lack of recent news catalysts. While some in the community see the recent pullback as a strategic entry point and remain bullish on the company's backlog and government contract pipeline, others are expressing concern over the lack of consistent operational progress and the stock's sensitivity to broader sector movements.

Pelican Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 23, 2024 and is headquartered in New York, NY.

Greenland Energy Co.

Greenland Energy is trending following its recent SPAC merger and Nasdaq debut, sparking intense debate over whether it represents a generational oil opportunity or a speculative scam. Community discussion is polarized between optimistic bulls highlighting the company's access to 13 billion barrels of potential oil reserves and skeptical traders warning of high volatility and inherent risks associated with early-stage resource exploration.

Monke, the Ethereum ape, trades with conviction and holds gems, striving to make it big and quit his 9-5 job.

Monke

$MONKE is gaining significant traction within the community due to continuous updates to its dedicated 'Monke Island' game and the expansion of its NFT ecosystem, which includes active staking rewards. Supporters are highlighting the project's resilience and community-driven development as key catalysts for their bullish outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Unicycive Therapeutics (UNCY) to Release Quarterly Earnings on Monday

Unicycive Therapeutics (NASDAQ:UNCY) will be releasing earnings before the market opens on Monday, March 30. (View Earnings Report at...

Unicycive Therapeutics (NASDAQ:UNCY) Shares Down 0.4% - Here's Why

Unicycive Therapeutics (NASDAQ:UNCY) Trading Down 0.4% - Should You Sell...

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the five brokerages that are currently covering the firm...

Unicycive Therapeutics (NASDAQ:UNCY) Stock Price Up 2.4% - Should You Buy?

Unicycive Therapeutics (NASDAQ:UNCY) Stock Price Up 2.4% - Still a Buy...

Analysts Set Expectations for UNCY FY2030 Earnings

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Analysts at HC Wainwright issued their FY2030 earnings per share estimates for Unicycive Therapeutics in a research report issued on Monday...

Unicycive Resubmits NDA For Oxylanthanum Carbonate To FDA

(RTTNews) - Unicycive Therapeutics, Inc. (UNCY) on Monday said it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration for oxylanthanum carbonate (OLC) for the...

Vivo Capital LLC Has $5.42 Million Stock Position in Unicycive Therapeutics, Inc. $UNCY

Vivo Capital LLC lowered its position in shares of Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) by 90.0% in the second quarter, according to its most recent 13F filing with the Securities...

Unicycive Therapeutics (NASDAQ:UNCY) Trading Up 5.6% - Time to Buy?

Unicycive Therapeutics (NASDAQ:UNCY) Trading 5.6% Higher - Time to Buy...

UNCY FY2025 EPS Boosted by Brookline Capital Management

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Research analysts at Brookline Capital Management boosted their FY2025 EPS estimates for Unicycive Therapeutics in a research report issued...

HC Wainwright Has Positive Outlook for UNCY FY2029 Earnings

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Research analysts at HC Wainwright boosted their FY2029 EPS estimates for Unicycive Therapeutics in a research note issued to investors on...

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Unicycive Therapeutics Inc

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

UNCY
Unicycive Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest UNCY News

UNCYUnicycive Therapeutics Inc